Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Souvenaid

EU flag

CHMP recommends tablet formulation of BeOne’s targeted cancer drug Brukinsa

The new formulation would allow blood cancer patients to halve their daily pill intake

- PMLiVE

The Considered appoints Rob Fuller as chief strategy officer

Fuller most recently served as the agency’s executive vice president, strategy and insight

- PMLiVE

Traitorous doubts

There’s a way to be more certain of your strategic decisions

Tim Wright, A&P

Genesis Research Group Appoints Tim Wright as Executive Vice President, Access and Pricing

Genesis Research Group, a leading provider of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, announces the appointment of Tim Wright as Executive Vice...

Genesis Research Group

- PMLiVE

Avalere Health appoints Jocelyn Crouch as head of brand strategy

Crouch most recently served as therapeutic lead, oncology and specialty medicine for international developed markets at Publicis Health

- PMLiVE

Why tariffs could fuel a new era of domestic pharma manufacturing

With tariffs threatening the sector’s low-cost sourcing playbook, pharma is being forced to rethink supply chain resilience from the ground up

ViiV Exhibition Stand

Apex Events and Exhibitions

GSK Exhibition Stand

Apex Events and Exhibitions

- PMLiVE

FDA approves Sobi’s Gamifant to treat severe inflammatory arthritis complication

The drug is now the first-ever therapy approved in the US to treat MAS in patients with Still's disease

- PMLiVE

Inizio Evoke appoints Kelly Cusumano as executive vice president, growth and client innovation

Cusumano previously served as executive vice president, managing director at Edelman

- PMLiVE

DCODE: your gateway to accelerating local innovation adoption in the UK

By Sabina Syed

- PMLiVE

Novartis and ProFound enter cardiovascular disease collaboration worth $750m per target

The companies will aim to discover and develop new therapeutics for the group of disorders

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links